FTRE
FTRE
NASDAQ · Life Sciences Tools & Services

Fortrea Holdings Inc

$18.43
+0.74 (+4.18%)
As of Aug 8, 10:09 PM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 10 59%
Hold 6 35%
Sell 1 6%
Price Target
Analyst Price Target +154.0% upside
Low Target $29.35
Average Target $46.82
High Target $58.56
Current Price $18.43
Current
$18.43
Target
$46.82
$29.35 $46.82 avg $58.56
Scenario Analysis
Bear Case
$29.35
59.3%
Low target
Base Case
$46.82
+154.0%
Avg target
Bull Case
$58.56
+217.7%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$21.39
-13.8% from high
52-Week Low
$5.82
+216.7% from low
Target vs 52W High
$46.82
+118.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -37.8%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -22.8%
A
Agilent Technologies Inc
Strong Buy 29 76% $64.69 -55.7%
WAT
Waters Corp
Hold 31 55% $189.60 -53.4%
IQV
Iqvia Holdings Inc
Strong Buy 28 79% $82.96 -65.2%
ILMN
Illumina Inc
Buy 28 61% $169.36 -9.9%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -61.5%